Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 5, 2003, Pages 535-537

  Cameron, E A B ^a   Binnie, J A H ^a   Balan, K ^a   Skerratt, S A ^a   Swift, A ^a   Solanki, C ^a   Middleton, S J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Colitis; Glucocorticoids; Radionuclide imaging; Synthetic; Ulcerative

Indexed keywords

PREDNISOLONE 3 SULFOBENZOATE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; DEPRESSION; DESCENDING COLON; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MALE; PRIORITY JOURNAL; RADIOLOGY; RECTUM; SCINTIGRAPHY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; TREATMENT OUTCOME;

EID: 0038627465     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310001914     Document Type: Article

References (8)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-8.
2. McIntyre PB, MacRae FA, Berghouse L, English J, Lennard-Jones JE. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 1985;26:822-4.
3. Hamilton I, Pinder IF, Dickinson RJ, Ruddell WS, Dixon MF, Axon AT. A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis. Dis Colon Rectum 1984;27:701-2.
4. Rollin C, Chosidow O, Diquet B, Dutreuil C, Herson S, Revuz J, et al. Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone. Eur J Clin Pharmacol 1993;44:395-9.
5. Luman W, Gray RS, Pendek R, Palmer KR. Prednisolone metasulphobenzoate foam retention enemas suppress the hypothalamo-pituitary-admnal axis. Aliment Pharmacol Ther 1994;8:255-8.
6. Ford GA, Oliver PS, Shepherd NA, Wilkinson SP. An Eudragitcoated prednisolone preparation for ulcerative colitis: pharmacokinetics and preliminary therapeutic use. Aliment Pharmacol Ther 1992;6:31-40.
7. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964;1:89.
8. m-HMPAO leucocyte scintigraphy in ulcerative colitis by comparison with histology. Br J Radiol 1995;68:1061-6.